title: Pharmaceutical approval update.
abstract: Truvada for HIV prevention, Xtandi for metastatic castration-resistant prostate cancer, and Marqibo, a vincristine liposome injection for acute myelogenous leukemia.
authors.forename: Marvin M
authors.initials: MM
authors.lastname: Goldenberg